Viewpoint: Esketamine promises to boost depression treatments—but we don't know enough about long-term effects - Genetic Literacy Project

Viewpoint: Esketamine promises to boost depression treatments—but we don't know enough about long-term effects  Genetic Literacy ProjectWith great fanfare, a new antidepressant entered the U.S. market in March , the first fundamentally new medicine for depression in decades. Based on the.